C123H245N21 — CID 167575328
1-(3-ethylcyclopentyl)-4-methylpiperidine;N-methyl-3-(3-methylazetidin-1-yl)cyclobutan-1-amine;N-methyl-4-(3-methylazetidin-1-yl)cyclohexan-1-amine;N-methyl-3-(3-methylazetidin-1-yl)cyclopentan-1-amine;N-methyl-3-(4-methylpiperidin-1-yl)cyclobutan-1-amine;N-methyl-4-(4-methylpiperidin-1-yl)cyclohexan-1-amine;1-methyl-4-(4-methylpiperidin-1-yl)piperidine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclobutan-1-amine;N-methyl-4-[(3S)-3-methylpyrrolidin-1-yl]cyclohexan-1-amine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclopentan-1-amine;4-methyl-1-(1-methylpyrrolidin-3-yl)piperidine (PubChem CID 167575328) has the molecular formula C123H245N21 and a molecular weight of 2018.46 g/mol. Its IUPAC name is 1-(3-ethylcyclopentyl)-4-methylpiperidine;N-methyl-3-(3-methylazetidin-1-yl)cyclobutan-1-amine;N-methyl-4-(3-methylazetidin-1-yl)cyclohexan-1-amine;N-methyl-3-(3-methylazetidin-1-yl)cyclopentan-1-amine;N-methyl-3-(4-methylpiperidin-1-yl)cyclobutan-1-amine;N-methyl-4-(4-methylpiperidin-1-yl)cyclohexan-1-amine;1-methyl-4-(4-methylpiperidin-1-yl)piperidine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclobutan-1-amine;N-methyl-4-[(3S)-3-methylpyrrolidin-1-yl]cyclohexan-1-amine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclopentan-1-amine;4-methyl-1-(1-methylpyrrolidin-3-yl)piperidine.
| Compound Name | 1-(3-ethylcyclopentyl)-4-methylpiperidine;N-methyl-3-(3-methylazetidin-1-yl)cyclobutan-1-amine;N-methyl-4-(3-methylazetidin-1-yl)cyclohexan-1-amine;N-methyl-3-(3-methylazetidin-1-yl)cyclopentan-1-amine;N-methyl-3-(4-methylpiperidin-1-yl)cyclobutan-1-amine;N-methyl-4-(4-methylpiperidin-1-yl)cyclohexan-1-amine;1-methyl-4-(4-methylpiperidin-1-yl)piperidine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclobutan-1-amine;N-methyl-4-[(3S)-3-methylpyrrolidin-1-yl]cyclohexan-1-amine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclopentan-1-amine;4-methyl-1-(1-methylpyrrolidin-3-yl)piperidine |
|---|---|
| PubChem CID | 167575328 |
| Molecular Formula | C123H245N21 |
| Molecular Weight | 2018.46 g/mol |
| Exact Mass | 2016.98 |
| IUPAC Name | 1-(3-ethylcyclopentyl)-4-methylpiperidine;N-methyl-3-(3-methylazetidin-1-yl)cyclobutan-1-amine;N-methyl-4-(3-methylazetidin-1-yl)cyclohexan-1-amine;N-methyl-3-(3-methylazetidin-1-yl)cyclopentan-1-amine;N-methyl-3-(4-methylpiperidin-1-yl)cyclobutan-1-amine;N-methyl-4-(4-methylpiperidin-1-yl)cyclohexan-1-amine;1-methyl-4-(4-methylpiperidin-1-yl)piperidine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclobutan-1-amine;N-methyl-4-[(3S)-3-methylpyrrolidin-1-yl]cyclohexan-1-amine;N-methyl-3-[(3S)-3-methylpyrrolidin-1-yl]cyclopentan-1-amine;4-methyl-1-(1-methylpyrrolidin-3-yl)piperidine |
| SMILES | CC1CCN(C2CCN(C)C2)CC1.CC1CCN(C2CCN(C)CC2)CC1.CCC1CCC(N2CCC(C)CC2)C1.CNC1CC(N2CC(C)C2)C1.CNC1CC(N2CCC(C)CC2)C1.CNC1CC(N2CC[C@H](C)C2)C1.CNC1CCC(N2CC(C)C2)C1.CNC1CCC(N2CC(C)C2)CC1.CNC1CCC(N2CCC(C)CC2)CC1.CNC1CCC(N2CC[C@H](C)C2)C1.CNC1CCC(N2CC[C@H](C)C2)CC1 |
| InChI | InChI=1S/C13H26N2.C13H25N.2C12H24N2.4C11H22N2.2C10H20N2.C9H18N2/c1-11-7-9-15(10-8-11)13-5-3-12(14-2)4-6-13;1-3-12-4-5-13(10-12)14-8-6-11(2)7-9-14;1-11-3-9-14(10-4-11)12-5-7-13(2)8-6-12;1-10-7-8-14(9-10)12-5-3-11(13-2)4-6-12;1-10-3-7-13(8-4-10)11-5-6-12(2)9-11;1-9-7-13(8-9)11-5-3-10(12-2)4-6-11;1-9-3-5-13(6-4-9)11-7-10(8-11)12-2;1-9-5-6-13(8-9)11-4-3-10(7-11)12-2;1-8-6-12(7-8)10-4-3-9(5-10)11-2;1-8-3-4-12(7-8)10-5-9(6-10)11-2;1-7-5-11(6-7)9-3-8(4-9)10-2/h11-14H,3-10H2,1-2H3;11-13H,3-10H2,1-2H3;11-12H,3-10H2,1-2H3;10-13H,3-9H2,1-2H3;10-11H,3-9H2,1-2H3;3*9-12H,3-8H2,1-2H3;2*8-11H,3-7H2,1-2H3;7-10H,3-6H2,1-2H3/t;;;10-,11?,12?;;;;9-,10?,11?;;8-,9?,10?;/m...0...0.0./s1 |
| InChIKey | GLHIGIZMPXIISE-ZFBSYWTCSA-N |
| XLogP | 17.89 |
| TPSA | 138.36 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 144 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2018.46 |
| LogP ≤ 5 | 17.89 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 21 |